ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZurichPolpharma Biologics Switzerland AG
Polpharma Biologics Switzerland AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Polpharma Biologics Switzerland AG develops and manufactures biosimilars. The company supports biosimilars from scientific development through commercial supply and provides development and manufacturing services.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Polpharma Biologics Switzerland AG

✓ Offered5
Development of biosimilars
Development of biosimilars from scientific assessment through cell line and process development to clinical development and submission.
Manufacturing of biosimilars
Manufacturing of biosimilars with development capabilities, GMP production, and support for the transition from development to commercial supply.
Biosimilar pipeline
Biosimilar portfolio with multiple programs in ophthalmology, multiple sclerosis, immunology, blood disorders, and asthma; some already approved, others in development.
Partnerships for biosimilar development and marketing
Partnerships with biotech and pharma partners for development, manufacturing, supply, licensing, and commercial marketing of biosimilars.
Biosimilar knowledge
Information on biosimilars, their manufacturing, clinical testing, safety, and the contribution to improved access and lower healthcare costs.
Trust & reputation

ranQ Trust Score of Polpharma Biologics Switzerland AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Polpharma Biologics Switzerland AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Polpharma Biologics Switzerland AG scores 74.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.75.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Polpharma Biologics Switzerland AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Polpharma Biologics Switzerland AG scores 85.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.85.74%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Polpharma Biologics Switzerland AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Polpharma Biologics Switzerland AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Polpharma Biologics Switzerland AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Polpharma Biologics Switzerland AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Polpharma Biologics Switzerland AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Lindenstrasse 22
8008 Zurich

At a glance

Legal form
Corporation
UID
CHE-327.161.086
Founded
2019 · 7 years
Last commercial register change
July 24, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.100.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    BB
    Biocon Biologics Switzerland AG
    Zurich
    AS
    Alvotech Swiss AG
    Zurich
    GA
    GlycoEra AG
    Wädenswil
    AP
    Advanz Pharma Specialty Medicine Switzerland GmbH
    Zurich
    LT
    Linkster Therapeutics AG
    Zurich
    AH
    AeoniQ Holding AG
    Schlieren
    MP
    Molecular Partners AG
    Schlieren
    VA
    Virometix AG
    Schlieren